![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 38/47 | (2006.01) |
A61P 25/00 | (2006.01) | ||
A61P 25/28 | (2006.01) | ||
A61K 9/19 | (2006.01) | ||
A61K 38/46 | (2006.01) |
(11) | Number of the document | 3626258 |
(13) | Kind of document | T |
(96) | European patent application number | 19192679.9 |
Date of filing the European patent application | 2011-06-25 | |
(97) | Date of publication of the European application | 2020-03-25 |
(45) | Date of publication and mention of the grant of the patent | 2021-08-04 |
(46) | Date of publication of the claims translation | 2021-12-10 |
(30) | Number | Date | Country code |
35885710 P | 2010-06-25 | US | |
36078610 P | 2010-07-01 | US | |
38786210 P | 2010-09-29 | US | |
201161435710 P | 2011-01-24 | US | |
201161442115 P | 2011-02-11 | US | |
201161476210 P | 2011-04-15 | US | |
201161495268 P | 2011-06-09 | US |
(72) |
ZHU, Gaozhong , US
LOWE, Kris , US
SHAHROKH, Zahra , US
CHRISTIAN, James , US
FAHRNER, Rick , US
PAN, Jing , US
WRIGHT, Teresa, Leah , US
CALIAS, Pericles , US
|
(73) |
Takeda Pharmaceutical Company Limited ,
1-1, Doshomachi 4-chome
Chuo-ku, Osaka-shi, Osaka,
JP
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Būdai ir kompozicijos, skirti iduronato-2-sulfatazės įvedimui į CNS |
METHODS AND COMPOSITIONS FOR CNS DELIVERY OF IDURONATE-2-SULFATASE |
Payment date | Validity (years) | Amount | |
2025-05-20 | 15 | 289.00 EUR |
2026-06-25 |